Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)
Dementia
About this trial
This is an interventional prevention trial for Dementia
Eligibility Criteria
Inclusion Criteria:
- People over 60 without dementia
- Agree to join the study and sign the consent form
- The Modified Rankin Scale (MRS) scores between 0-1 points
- Education level: elementary or higher education (6 years) or can read and write Chinese
- Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist.
- Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months.
Exclusion Criteria:
- Have been diagnosed with any kind of dementia
- Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit
- Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year)
- Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study
- Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study.
- Drug or alcohol abuse in the last year
- Overlapping with other interventional trials at the same time which may affect the evaluation results.
Sites / Locations
- Taipei Medical University-Shuang Ho HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Placebo Comparator
On-site
Remote
Control
The on-site multi-modal intervention will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol.
The remote intervention group is designed for reducing the chances of person-to-person contact response to the current COVID-19 pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs.
The control group will also receive the same health evaluation and education as all intervention groups.